Page 24 - Nasdaq Regn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Almanack Investment Partners LLC. cut its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 11.1% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,400 shares of the biopharmaceutical company’s stock after selling 800 shares during the period. Regeneron Pharmaceuticals comprises […]

First Foundation Advisors decreased its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 4.1% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 3,229 shares of the biopharmaceutical company’s stock after selling 138 shares during the period. First Foundation Advisors’ holdings in Regeneron […]

Jefferies Financial Group Inc. lessened its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 51.7% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 9,600 shares of the biopharmaceutical company’s stock after selling 10,275 shares during the quarter. Jefferies Financial […]

Panagora Asset Management Inc. grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 156,080 shares of the biopharmaceutical company’s stock after purchasing an additional 8,677 shares […]

Panagora Asset Management Inc. lifted its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.9% in the 2nd quarter, HoldingsChannel reports. The fund owned 156,080 shares of the biopharmaceutical company’s stock after purchasing an additional 8,677 shares during the quarter. Regeneron Pharmaceuticals comprises 0.7% of Panagora Asset Management Inc.’s investment portfolio, making the […]